The reiteration of a Buy rating and maintenance of a high price target by a reputable analyst like Michael Schmidt from Guggenheim could lead to increased investor confidence in Immunocore Holdings. This endorsement is likely to have a positive short-term impact on the stock's price as it reaffirms the company's strong prospects in the eyes of influential market analysts.